vanilmandelic acid has been researched along with Ehlers-Danlos Syndrome in 1 studies
Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.
Ehlers-Danlos Syndrome: A heterogeneous group of autosomally inherited COLLAGEN DISEASES caused by defects in the synthesis or structure of FIBRILLAR COLLAGEN. There are numerous subtypes: classical, hypermobility, vascular, and others. Common clinical features include hyperextensible skin and joints, skin fragility and reduced wound healing capability.
Excerpt | Relevance | Reference |
---|---|---|
"Disulfiram was orally given, in addition to a parenteral administration of copper-histidine in the case of MD patients." | 2.77 | Effects of disulfiram treatment in patients with Menkes disease and occipital horn syndrome. ( Kodama, H; Ogawa, E, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ogawa, E | 1 |
Kodama, H | 1 |
1 trial available for vanilmandelic acid and Ehlers-Danlos Syndrome
Article | Year |
---|---|
Effects of disulfiram treatment in patients with Menkes disease and occipital horn syndrome.
Topics: Adolescent; Adult; Ceruloplasmin; Copper; Cutis Laxa; Disulfiram; Dopamine; Ehlers-Danlos Syndrome; | 2012 |